| Identification | |
| Name: | 3,5-Pyridinedicarboxylicacid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-methyl5-[(3R)-1-(phenylmethyl)-3-piperidinyl] ester, hydrochloride (1:1), (4R)-rel- |
| Synonyms: | 3,5-Pyridinedicarboxylicacid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl(3R)-1-(phenylmethyl)-3-piperidinyl ester, monohydrochloride, (4R)-rel- (9CI);Coniel;KW 3049; |
| CAS: | 91599-74-5 |
| Molecular Formula: | C28H32ClN3O6 |
| Molecular Weight: | 542.03 |
| InChI: | InChI=1S/C28H31N3O6.ClH/c1-18-24(27(32)36-3)26(21-11-7-12-22(15-21)31(34)35)25(19(2)29-18)28(33)37-23-13-8-14-30(17-23)16-20-9-5-4-6-10-20;/h4-7,9-12,15,23,26,29H,8,13-14,16-17H2,1-3H3;1H/t23-,26-;/m1./s1 |
| Molecular Structure: |  |
| Properties | |
| Density: | g/cm3 |
| Specification: |
Benidipine hydrochloride (91599-74-5) also can be called Coniel ; Coniel R ; (+-)-Benidipine hydrochloride ; (-)-alpha-Benidipine hydrochloride ; Benidipine hydrochloride (JP15) . |
| Biological Activity: | Orally active antihypertensive agent which displays a wide range of activities in vitro and in vivo . Inhibits L-, N- and T-type Ca 2+ channels. Also inhibits aldosterone-induced mineralocorticoid receptor activation. Exhibits cardioprotective and antiartherosclerotic effects. |
| Storage Temperature: | Desiccate at RT |
| Usage: | A dihydropyridine calcium channel blocker |
| Safety Data | |
 |
|
